Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, August 6, 2021
[ Fri, Aug 06th 2021
] - WOPRAI
[ Fri, Aug 06th 2021
] - WOPRAI
[ Fri, Aug 06th 2021
] - WOPRAI
[ Fri, Aug 06th 2021
] - WOPRAI
[ Fri, Aug 06th 2021
] - WOPRAI
[ Fri, Aug 06th 2021
] - WOPRAI
[ Fri, Aug 06th 2021
] - WOPRAI
[ Fri, Aug 06th 2021
] - WOPRAI
[ Fri, Aug 06th 2021
] - WOPRAI
Thu, August 5, 2021
[ Thu, Aug 05th 2021
] - WOPRAI
[ Thu, Aug 05th 2021
] - WOPRAI
[ Thu, Aug 05th 2021
] - WOPRAI
[ Thu, Aug 05th 2021
] - WOPRAI
[ Thu, Aug 05th 2021
] - WOPRAI
[ Thu, Aug 05th 2021
] - WOPRAI
[ Thu, Aug 05th 2021
] - WOPRAI
[ Thu, Aug 05th 2021
] - WOPRAI
[ Thu, Aug 05th 2021
] - WOPRAI
[ Thu, Aug 05th 2021
] - WOPRAI
[ Thu, Aug 05th 2021
] - WOPRAI
[ Thu, Aug 05th 2021
] - WOPRAI
[ Thu, Aug 05th 2021
] - WOPRAI
[ Thu, Aug 05th 2021
] - WOPRAI
[ Thu, Aug 05th 2021
] - WOPRAI
[ Thu, Aug 05th 2021
] - WOPRAI
[ Thu, Aug 05th 2021
] - WOPRAI
[ Thu, Aug 05th 2021
] - WOPRAI
[ Thu, Aug 05th 2021
] - WOPRAI
[ Thu, Aug 05th 2021
] - WOPRAI
Tazeen Ahmad Maintained (SRPT) at Strong Buy with Decreased Target to $122 on, Aug 5th, 2021
Tazeen Ahmad of B of A Securities, Maintained "Sarepta Therapeutics, Inc." (SRPT) at Strong Buy with Decreased Target from $135 to $122 on, Aug 5th, 2021.
Tazeen has made no other calls on SRPT in the last 4 months.
There are 2 other peers that have a rating on SRPT. Out of the 2 peers that are also analyzing SRPT, 1 agrees with Tazeen's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $93 on, Monday, April 19th, 2021
This is the rating of the analyst that currently disagrees with Tazeen
- Yun Zhong of "BTIG" Initiated at Strong Buy and Held Target at $110 on, Tuesday, June 15th, 2021
